Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Rechsteiner

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 15, 2011
Characterization of periostin isoform pattern in non-small cell lung cancerLaura Morra, Markus Rechsteiner, Silvia Casagrande, et al.
Nature Communications|May 22, 2026
A scalable Tn5-based method for genome-wide DNA methylation profiling in development and diseaseHanrong Hu, Nahuel Simonet, Ece Naz Bilgiç, et al.
Human Pathology|February 24, 2020
Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutationsCarole Guillet, Markus Rechsteiner, Elisa Bellini, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2018
Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological featuresMarkus Rechsteiner, Konstantin Dedes, Daniel Fink, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 21, 2026
Atypical Ductular Reactions Are a Distinct Regenerative Phenomenon in Hepatocellular Carcinoma (HCC) Patients after Transarterial ChemoembolizationOrnella Wolff, Adrian Kobe, Laure-Alix Clerbaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2014
Intratumor heterogeneity in hepatocellular carcinomaJuliane Friemel, Markus Rechsteiner, Lukas Frick, et al.
Oncotarget|June 6, 2019
Melanoma patients with additional primary cancers: a single-center retrospective analysisFlorentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, et al.
Experimental and Molecular Pathology|August 23, 2013
TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous typeMarkus Rechsteiner, Anne-Katrin Zimmermann, Peter J Wild, et al.
Targeted Oncology|September 22, 2022
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET geneAlessa Fischer, Lorenz Bankel, Stefanie Hiltbrunner, et al.
JCO Precision Oncology|January 7, 2022
Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal CancerDilara Akhoundova, Heike Pietge, Saskia Hussung, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|November 15, 2011
Characterization of periostin isoform pattern in non-small cell lung cancerLaura Morra, Markus Rechsteiner, Silvia Casagrande, et al.
Nature Communications|May 22, 2026
A scalable Tn5-based method for genome-wide DNA methylation profiling in development and diseaseHanrong Hu, Nahuel Simonet, Ece Naz Bilgiç, et al.
Human Pathology|February 24, 2020
Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutationsCarole Guillet, Markus Rechsteiner, Elisa Bellini, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2018
Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological featuresMarkus Rechsteiner, Konstantin Dedes, Daniel Fink, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 21, 2026
Atypical Ductular Reactions Are a Distinct Regenerative Phenomenon in Hepatocellular Carcinoma (HCC) Patients after Transarterial ChemoembolizationOrnella Wolff, Adrian Kobe, Laure-Alix Clerbaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2014
Intratumor heterogeneity in hepatocellular carcinomaJuliane Friemel, Markus Rechsteiner, Lukas Frick, et al.
Oncotarget|June 6, 2019
Melanoma patients with additional primary cancers: a single-center retrospective analysisFlorentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, et al.
Experimental and Molecular Pathology|August 23, 2013
TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous typeMarkus Rechsteiner, Anne-Katrin Zimmermann, Peter J Wild, et al.
Targeted Oncology|September 22, 2022
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET geneAlessa Fischer, Lorenz Bankel, Stefanie Hiltbrunner, et al.
JCO Precision Oncology|January 7, 2022
Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal CancerDilara Akhoundova, Heike Pietge, Saskia Hussung, et al.
Pageof 5